Skip to main content
SpringerLink
Log in

Muskelrelaxanzien

  • Chapter
Anästhesiologie

  • 45 Accesses

Zusammenfassung

Bald nach der Entdeckung der Neuen Welt gelangten mehr oder weniger phantastische Mitteilungen über ein tödliches Pfeilgift der Indianer des Orinoko- und Amazonasbeckens Südamerikas nach Europa. In Sir Walter Raleighs Bericht über seine Reise nach Guyana (1594/95) wird dieses Gift „ourai“ genannt, das später unter dem Namen Curare allgemein bekannt wurde.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adams AK, Salt PJ (1985) The use of neuromuscular 19. blocking agents in opthalmic surgery. Clin Anaesth 3:435 —445 20.

    Google Scholar 

  2. Agoston S, Richardson FJ (1985) Pipecuronium bromide ( Arduan)- a new long-acting non-depolarizing neuromuscular blocking drug. Clin Anaesth 3: 361–369

    Google Scholar 

  3. Agoston S, Vermeer GA, Kersten UW, Scaf AHJ 21. (1978) A preliminary investigation of the renal and hepatic excretion of galamine triethiodide in man Br J Anaeth 50: 345–351

    CAS  Google Scholar 

  4. Ali HH, Brull SJ, Witkowski T, Kopman A, Silverman 22. DG, Goudsouzian NG, Bartkowski R, Weakly N (1993) Efficacy and safety of divided dose administra- tion of mivacurium for rapid tracheal intubation. 23. Anesthesiology A934

    Google Scholar 

  5. Arden JR, Lynam DP, Castagnoli Kg Canfell PC, Cannon JG, Miller RD (1988) Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 68: 771–776

    PubMed  CAS  Google Scholar 

  6. Assem ESK, Symons IE (1989) Anaphylaxis due to suxamethonium in a 7-year-old child: a 14-year follow up with allergy testing. Anaesthesia 44: 121–124

    PubMed  CAS  Google Scholar 

  7. Azar I (1984) The response of patients with neuromuscular disorders to muscle relaxants: a review. Anesthesiology 61: 173 —187

    Google Scholar 

  8. Azar I, Pham AN, Karambelkar DJ, Lear E (1983) The heart rate following edrophonium-atropine and edrophonium-glycopyrrolate mixtures. Anesthesiology 59: 139–141

    Google Scholar 

  9. Baraka A (1977) Self-taming of succinylcholine-induced fasciculations. Anesthesiology 46: 292–293

    PubMed  Google Scholar 

  10. Baraka A, Yazigi A (1987) Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic paturient. Anesthesiology 67: 806–808

    PubMed  CAS  Google Scholar 

  11. Bartunek A, Huemer G, Gilly H, Yildiz, S, Lackner FX (1994) Neostigmine and edrophonium reversal of mivacurium induced neuromuscular block. Anesthesiology 81: A1066

    Google Scholar 

  12. Basta SJ (1992) Clinical pharmacology of mivacurium chloride: a review. J Clin Anaesth 4:153 —163

    CAS  Google Scholar 

  13. Basta SJ, Ali HH, Savarese JJ, Sunder N, Gionfriddo M, Cloutier G, Lineberry C, Cato AE (1982) Clinical pharmacology of atracurium besylate (BW 33A): a new nondepolarizing muscle relaxant. Anesth Analg 61: 723 —729

    PubMed  CAS  Google Scholar 

  14. Basta SJ, Debros F, Savarese JJ, Ali HH, Embree P, Lai A, Schwartz A, De Angelis R, Gallagher M, James N (1988) BW A938U pharmacokinetics and dynamics in healthy surgical patients under isoflurane anesthesia. Anesth Analg 67: S9

    Google Scholar 

  15. Basta SJ, Savarese JJ, Ali HH, Sunder N, Moss J, Gionfriddo M, Embree P (1983) Vecuronium does not alter serum histamine within the clinical dose range. Anesthesiology 59: A273

    Google Scholar 

  16. Bencini AF, Scaf AHJ, Sohn YJ, Kersten-Klett UW, Agoston S (1986) Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 58: 988–995

    PubMed  CAS  Google Scholar 

  17. Bencini AF, Scaf AHJ, Sohn YJ, Meistelmann C, Lien-hart A, Kerstern UW, Schwarz S, Agoston S (1986) Disposition and urinary excretion of vecuronium bromide in anesthetized patients with normal renal function of renal failure. Anesth Analg 65:245 —251

    Google Scholar 

  18. Bevan DR, Bevan JC, Donati F (1988) Muscle relaxants in clinical anesthesia. Year Book Medical Publishers, Chicago London

    Google Scholar 

  19. Bevan DR, Donati F, Kopman AF (1992) Reversal of neuromuscular blockade. Anesthesiology 77: 785–805

    PubMed  CAS  Google Scholar 

  20. Bevan DR, Fiset P, Balendran P, Law-Min JC, Ratcliffe A, Donati F (1993) Pharmacodynamic behaviour of rocuronium in the elderly. Can J Anaesth 40:127132

    Google Scholar 

  21. Bikhazi GB, Leung I, Flores C, Mikati HMJ, Foldes FF (1988) Potentiation of neuromsucular blocking agents by calcium channel blockers in rats. Anesth Analg 67: 1–8

    PubMed  CAS  Google Scholar 

  22. Birch AA, Mitchell GD, Playford GA, Lang CA (1969) Changes in serum potassium response to succinylcholine following trauma. JAMA 210: 490–493

    CAS  Google Scholar 

  23. Boehm R (1897) Ueber Curare and Curerealkaloide. Arch Pharmakol 235: 660

    Google Scholar 

  24. Bossa R, Galatulas I (1985) Neuromuscular blocking activity of H2 receptor antagonists. Br J Pharmacol [Suppl] 86: 779 P

    Google Scholar 

  25. Bovet D, Bovet-Nitti F, Guarino S, Longo VG, Marotta

    Google Scholar 

  26. M (1949) Proprieta farmachodinamiche di alcuni derivati della succinilcolina dotati di azione curarica. Rend Inst Sup Sanita (Roma) 12: 106

    Google Scholar 

  27. Bowman WC (1980) Prejunctional and post junctional cholinoceptors at the neuromuscular junction. Anesth Analg 59: 935–943

    PubMed  CAS  Google Scholar 

  28. Bowman WC, Marshall IG, Gibb AJ (1985) Is there feedback control of transmitter release at the neuromuscular junction? In: Katz RL (ed) Muscle relaxants. Grune & Stratton, Orlando, p 39

    Google Scholar 

  29. Brett RS, Schmidt JH, Grage JS, Schartel SA, Poppers PJ (1987) Measurement of acetylcholine receptor concentration in skeletal muscle from a patient with multiple sclerosis and resistence to atracurium. Anesthesiology 66: 837–839

    PubMed  CAS  Google Scholar 

  30. Brom van den RHG, Wierda JMKH, Agoston S (1987) Pharmacokinetics of atracurium and metabolites in normal and renal failure patients. Anesthesiology 67: A606

    Google Scholar 

  31. Bros de F, Basta SJ, Ali HH, Wargin W, Welch R (1987) Pharmacokinetics and pharmacodynamics of BW B 1090U in healthy surgical patients receiving N2O/02 isoflurane anesthesia. Anesthesiology 67: A609

    Google Scholar 

  32. Bros de F, Goudsouzian N, Chakravorty S, Patel S, Cook DR (1994) Pharmacokinetic evaluation of the cis-cis isomer, alcohol and ester metabolites of mivacurium during prolonged infusions in neurological patients. Anesthesiology 81: A1085

    Google Scholar 

  33. Bros de F, Okutani R, Lai A, Lawrence KW, Basta S (1987) Phenytoin does not interfere with atracurium pharmacokinetics and pharmacodynamics. Anesthesiology 67: A607

    Google Scholar 

  34. Brotherton WP Matteo RS (1981) Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure. Anesthesiology 55: 273–276

    PubMed  CAS  Google Scholar 

  35. Brücke H, Ginzal KH, Klupp H, Pfaffenschlager F, Werner G (1951) Bis-cholinester von Dicarbonsäuren als Muskelrelaxantien in der Narkose. Wien Klin Wochenschr 63: 464

    PubMed  Google Scholar 

  36. Burns BD, Paton WDM (1951) Depolarization of the motor endplate by decamethonium and acetylcholine. J Physiol (Lond) 115: 41–73

    CAS  Google Scholar 

  37. Bush GH (1985) Neuromuscular blockade. Use in paediatric surgery and intensive care. Clin Anaesth 3: 405–420

    Google Scholar 

  38. Buzello W, Agoston S (1978) Comparative clinical pharmacokinetics of tubocurarine, gallamine, alcuronium and pancuronium. Anaesthesist 27: 313

    PubMed  CAS  Google Scholar 

  39. Buzello W, Huttarsch H (1988) Muscle relaxation in patients with Duchenne’s muscular dystrophy. Use of vecuronium in two cases. Br J Anaesth 60: 228

    Google Scholar 

  40. Buzello W, Schluermann D, Pollmaecher T, Spillner G (1987) Unequal effects of cardiopulmonary bypass-induced hypothermia on neuromuscular blockade from constant infusion of alcuronium, d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 66: 842

    PubMed  CAS  Google Scholar 

  41. Buzello W, Williams SCH, Chandra P, Watkins ML, Dozier DS (1985) Vecuronium and porcine malignant hyperthermia. Anesth Analg 64: 515

    PubMed  CAS  Google Scholar 

  42. Camp CE, Tessem J, Adenwala J, Joyce TH (1987) Vecuronium and prolonged neuromuscular blockade in postpartum patients. Anesthesiology 67: 1006–1008

    PubMed  CAS  Google Scholar 

  43. Cannon JE, Fahey MR, Castagnoli K1 Furuta T, Canfell PC, Sharma M, Miller RD (1987) Continuous infusion of vecuronium: the effect of anesthetic agents. Anesthesiology 67: 503

    PubMed  CAS  Google Scholar 

  44. Changeux JP, Devillers-Thiery A, Chemonilli P (1984) Acetylcholine rezeptor. An allosteric membrane protein. Science 225: 1335

    Google Scholar 

  45. Chapple DJ, Clarke JS (1983) Pharmacological action of breakdown products of atracurium and related substances. Br J Anaesth 55: 11S - 15S

    PubMed  Google Scholar 

  46. Churchill-Davidson HC, Christie TH, Wise RP (1960) Dual neuromuscular block in man. Anesthesiology 21: 144–149

    PubMed  CAS  Google Scholar 

  47. Churchill-Davidson HC, Wise RP (1964) The response of the newborn infant to muscle relaxants. Can Anaesth Soc J 11: 1

    PubMed  CAS  Google Scholar 

  48. Collier C (1975) Suxamethonium pains and fasciculations. Proc R Soc Med 68: 105–108

    PubMed  CAS  Google Scholar 

  49. Connolly FM, Loan PB, Mirakhur RK, McCoy EP (1994) Comparison of succinylcholine and rocuronium for rapid sequence induction of anesthesia. Anesthesiology 81: A1072

    Google Scholar 

  50. Cook DR, Fisher CG (1975) Neuromuscular blocking effects of succinylcholine in infants and children. Anesthesiology 42: 662–665

    PubMed  CAS  Google Scholar 

  51. Cook DR, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, Harrelson JC, Welch RM, Samara B (1992) Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 69: 580585

    Google Scholar 

  52. Cook DR, Stiller RL, Weakly JN, Chakravorti S, Bran-dom BW, Welch RM (1989) In vitro metabolism of mivacurium chlorid (BW B1090U) and succinylcholine. Anesth Analg 68: 452–456

    PubMed  CAS  Google Scholar 

  53. Cooper R, Maddineni VR, Mirakhur MD, Fee JPH (1992) Influence of dose and anesthetic technique on the onset and duration of action of rocuronium (Org 9426). Anesthesiology 77: A905

    Google Scholar 

  54. Cowgill DB, Mostello LA, Shapiro HM (1974) Encephalitis and a hyperkalemic response to succinylcholine. Anesthesiology 40: 409–411

    PubMed  CAS  Google Scholar 

  55. Cronelly R, Fischer DM, Miller RD, Gencarelli P, Nguyen-Gruenke L, Castagnoli N (1983) Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans. Anesthesiology 58: 405–408

    Google Scholar 

  56. Cronelly R, Morris RB (1982) Antagonism of neuromuscular blockade. Br J Anaesth 54: 183–193

    Google Scholar 

  57. Crul JF (1981) Klinische Pharmakokinetik von Succinylcholin. In: Buzello W (Hrsg) Muskelrelaxantien. Thieme, Stuttgart New York (Intensivmed Notfallmed Anästh, Bd 30, S 91 )

    Google Scholar 

  58. Dailey PA, Fischer DM, Shnider SM, Baysinger CL, Shinohara Y, Miller RD, Abboud TK, Kim KC (1984) Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section. Anesthesiology 60: 569–574

    PubMed  CAS  Google Scholar 

  59. Dale HH, Feldberg W (1934) Chemical transmission at motor nerve endings in voluntary muscle transmission at motor nerve endings in voluntary muscle. J Physiol (Lond) 81: 39

    CAS  Google Scholar 

  60. Dale HH, Feldberg W, Vogt M (1936) Release of acetylcholine at voluntary motor nerve endings. J. Physiol (Lond) 86: 353

    CAS  Google Scholar 

  61. Day NS, Blake GJ, Standaert FG, Dretchen KL (1983) Characterization of the train of four response in fast and slow muscles: effect of d-tubocurarine, pancuronium, and vecuronium. Anesthesiology 58: 414–417

    PubMed  CAS  Google Scholar 

  62. Denman W, Goudsouzian N, Gelb C (1992) Comparison of neuromuscular, cardiovascular and histamine releasing properties of doxacurium and pipecuronium. Anesthesiology 77: A955

    Google Scholar 

  63. Denny NM, Kneeshaw JD (1986) Vecuronium and atracurium infusions during hypothermic cardiopulmonary bypass. Anaesthesia 41: 919–922

    PubMed  CAS  Google Scholar 

  64. Deriaz H, Schmautz E, Vrillon M, Lienhart A (1994) Pharmacodynamics of repeated doses of 51W89 during surgery. Anesthesiology 81: A1092

    Google Scholar 

  65. Devcic A, Munshi C, Gandhi S (1994) Mivacurium reversal: edrophonium vs. neostigmine. Anesthesiology 81: A1067

    Google Scholar 

  66. Doenicke A (1974) Pseudocholinesterasen. In: Schwiegk H (Hrsg) Handbuch der inneren Medizin Bd 7, Teil 1. Springer, Berling Heidelberg New York, S 761

    Google Scholar 

  67. Doenicke A, Gärtner T, Kreutzberg G, Remes J, Spiess W, Steinbereithner K (1963) Serum Cholinesterase Anenzymia. Acta Anaesthesiol Scand 7: 59

    PubMed  CAS  Google Scholar 

  68. Doenicke A, Holle F, Frey HH (1962) Praktische Bedeutung der Plasmacholinesterasebestimmung and ihres atypischen Verhaltens gegenüber Succinylbischolin. Anaesthesist 11: 146

    PubMed  CAS  Google Scholar 

  69. Doenicke A, Krumey I, Kugler J, Klempa J (1968) Experimental studies of the breakdown of epontol: Determination of propanidid in human serum. Br J Anaesth 40: 415–428

    Google Scholar 

  70. Doenicke A, Mayer M, Nebauer AE, Lorenz W, Moss J, Peter K (1993) Mivacurium and histamine levels: oral premedication with H1/H2 antagonists prevents side effects. Anesthesiology 79: A931

    Google Scholar 

  71. Doenicke A, Moos J, Lorenz W, Hoernecke R, Gottardis M (1994) Are hypotension and rash after atracurium really caused by histamine release. Anesth Analg 78: 967–972

    PubMed  CAS  Google Scholar 

  72. Doenicke A, Schmidinger ST, Krumey I (1968) Suxmethonium and serum cholinesterase. Br J Anaesth 40: 834

    PubMed  CAS  Google Scholar 

  73. Dominique C, d’Honneur G, Khalil M, Schoeffler P, Duvaldestin P (1992) Pipecuronium pharmacokinetics and pharmacodynamics in patients with cirrhosis. Anesthesiology 77: A938

    Google Scholar 

  74. Donati F, Antzaka C, Bevan DR (1986) Potency of pancuronium at the diaphragm and the adductor pollicis muscle in humans. Anesthesiology 65: 1–5

    PubMed  CAS  Google Scholar 

  75. Donati F, Bevan DR (1985) Suxamethonium. Clin Anaesth 3: 371–385

    Google Scholar 

  76. Donati F, McCaroll SM, Antzaka C, McCready D, Bevan DR (1987) Dose-response curves for edrophonium, neostigmine, and pyridostigmine after pancuronium and d-tubocurarine. Anesthesiology 66: 471–476

    PubMed  CAS  Google Scholar 

  77. Donlon JV, Savarese JJ, Ali HH, Teplik RS (1980) Human dose-response curves for neuromuscular blocking drugs. A comparison of two methods of constructions and analysis. Anesthesiology 53: 161

    Google Scholar 

  78. Duncalf D, Chaudrey I, Aoki T, Nagashima H, Foldes FF (1983) Potentiation of pancuronium, vecuronium and atracurium by d-tubocurarine or metocurine. Anesthesiology 59: A292

    Google Scholar 

  79. Duvaldestin P, Agoston S, Henzel D, Kersten UW, Desmonts JM (1978) Pancuronium pharmacokinetics in patients with liver cirrhosis. Br J Anaesth 50: 1131–1136

    PubMed  CAS  Google Scholar 

  80. Duvaldestin P, Berger JL, Videcoq M, Desmonts JM (1982) Pharmacokinetics and pharmacodynamies of ORG NC45 in patients with cirrhosis. Anesthesiology 57: A238

    Google Scholar 

  81. Duvaldestin P, Henzel D, Demetriou M, Desmonts JM (1978) Pharmacokinetics of fazadinium in man. Br J Anaesth 50: 773–777

    PubMed  CAS  Google Scholar 

  82. Duvaldestin P, Lebrault C, Chauvin M (1985) Pharmakokinetics of muscle relaxants in patients with liver disease. Clin Anaesth 3: 293–306

    Google Scholar 

  83. Duvaldestin P, Saada A, Berger JL, d’Hollander A, Desmonts JM (1982) Pharmacokinetics, pharmacodynamics, and dose-response relationships of pancuronium in control and elderly subjects. Anesthesiology 56: 36–40

    PubMed  CAS  Google Scholar 

  84. Ebeling BJ, Müller W (1993) Pharmacokinetic and pharmacodynamic parameters of vecuronium in young and elderly patients. Anesthesiology 79: A960

    Google Scholar 

  85. Eisenkraft JB, Book WJ, Papatestas AE, Hubbard M (1989) Sensitivity to vecuronium in myasthenia gravis: a dose-response study. Anesth Analg 68: S 80

    Google Scholar 

  86. Engbaeck L (1954) The pharmacological actions of magnesium ions with particular reference to the neuromuscular and cardiovascular systems. Pharmacol Rev 4: 396–410

    Google Scholar 

  87. Erkola O (1988) Prevention of succinylcholine-induced muscle pains with alcuronium, atracurium, d-tubocurarine and vecuronium. 9th W Congr Abstr Scient Pap II: A0569

    Google Scholar 

  88. Erkola O, Rautoma P, Meretoja OA (1994) Pancuronium makes mivacurium Atracurium longacting muscle relaxant. Anesthesiology 81: A1061

    Google Scholar 

  89. Everett AJ, Lowe LA, Wilkinson S (1970) Revision of the structure of (+)-tubocurarine chloride and (+)chondrocurarine. J Chem Soc 16: 1020–1021

    Google Scholar 

  90. Fahey MR, Hosobuchi Y, Canfell C, Tabaoda T, Shi WZ, Miller RD (1985) Cerebrospinal fluid concentrations of laudanosione in man. Anesthesiology 63: A312

    Google Scholar 

  91. Fahey MR, Morris RB, Miller RD, Nguyen TL, Upton RA (1981) Pharmacokinetics of Org NC45 ( Norcuron) in patients with and without renal failure. Br J Anaesth 53: 1049–1053

    Google Scholar 

  92. Fahey MR, Rupp SM, Fisher DM, Miller RD, Sharma M, Canfell C, Castagnoli K, Hennis PJ (1984) The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 61: 699–702

    PubMed  CAS  Google Scholar 

  93. Fahey MR, Rupp SM, Canfell C, Fisher DM, Miller RD, Sharma M, Castagnoli K, Hennis PJ (1985) Effect of renal failure on laudanosin excretion in man. Br J Anaesth 57: 1049–1051

    PubMed  CAS  Google Scholar 

  94. Farman JV, Turner JM, Blanloeil Y (1986) Atracurium infusion in liver transplantation. Br J Anaesth 58: 96S

    Google Scholar 

  95. Farrell AM, Gowland G, Mc Dowell JM, Simpson KH, Watkins J (1988) Anaphylactoid reaction to vecuronium followed by systemic reaction to skin testing. Anaesthesia 43: 207–209

    PubMed  CAS  Google Scholar 

  96. Feldman SA (1987) Neuromuscular blocking agents. In: Feldman SA, Scurr CF, Paton W (eds) Drugs in anaesthesia: mechanisms of action. Arnod, London, p 160–179

    Google Scholar 

  97. Feldman SA, Liban JB (1987) Vecuronium–a variable dose technique. Anaesthesia 42: 199–201

    PubMed  CAS  Google Scholar 

  98. Fisher DM, Canfell PC, Miller RD (1984) Stability of atracurium administered by infusion. Anesthesiology 61: 347–348

    PubMed  CAS  Google Scholar 

  99. Fisher DM, Canfell PC, Fahey MR, Rosen JI, Rupp SM, Sheiner LW, Miller RD (1986) Elimination of atracurium in humans• contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 65: 6–12

    PubMed  CAS  Google Scholar 

  100. Fisher DM, Cronnelly R, Sharma M, Miller RD (1984) Clinical pharmacology of edrophonium in infants and children. Anesthesiology 61: 428–433

    PubMed  CAS  Google Scholar 

  101. Fisher DM, Miller RD (1983) Neuromuscular effects of vecuronium (ORG NC45) in infants and children during N2O, halothane anesthesia. Anesthesiology 58: 519–523

    PubMed  CAS  Google Scholar 

  102. Fisher DM, Rosen JI (1986) A pharmacokinetic explanation for increasing recovery time following larger or repeated doses of nondepolarizing muscle relaxants. Anesthesiology 65: 286–291

    PubMed  CAS  Google Scholar 

  103. Fisher MMCD (1978) Anaphylactic reactions to galla-mine triethiodide. Anaesth Intensiol Care 6: 62

    CAS  Google Scholar 

  104. Fisher MMCD (1982) The epidemiology of anaesthetic anaphylactoid reactions in Australasia. Klin Wochenschr 60: 11017–11020

    Google Scholar 

  105. Flashburg M, Molbegott L, Baker T (1993) Speed and ease of endotracheal intubation at 75 seconds after prior priming at two, three and five minutes with mivacurium compared to succinylcholine at 75 seconds. Anesthesiology 79: A935

    Google Scholar 

  106. Fogdall RP, Miller RD (1975) Neuromuscular effects of enflurane, alone and combined with d-tubocurarine, pancuronium, and succinylcholine, in man. Anesthesiology 42: 173–177

    PubMed  CAS  Google Scholar 

  107. Foldes FF, McNall PG, Borrego-Hinjose JH (1952) Succinylcholine: a new approach to muscular relaxation in anaesthesiology. N Engl J Med 247: 596

    PubMed  CAS  Google Scholar 

  108. Foldes FF, Nagashima H, Nguyen HD, Weiss R, Goldiner PL (1986) The human cumulative dose-response of pipecuronium bromide under balanced anesthesia. Anesthesiology 65: A116

    Google Scholar 

  109. Foldes FF, Nagashima H, Nguyen HD, Schiller WS, Mason MM, Ohta Y (1991) The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. Anesthesiology 75: 191–196

    PubMed  CAS  Google Scholar 

  110. Forbes AR, Cohen NH, Eger EI (1979) pancuronium reduces halothane requirement in man. Anesth Analg 58: 497–499

    Google Scholar 

  111. Forstmann V, Schuh FT (1988) Wirkungseintritt and Intubationsbedingungen nach Atracurium, Vecuronium and Suxamethonium, Anaesthesist 37: 311

    Google Scholar 

  112. Frankville DD, Drummond JC (1987) Hyperkalemia after succinylcholine administration in a patient with closed head injury without paresis. Anesthesiology 67: 264–266

    PubMed  CAS  Google Scholar 

  113. Futo J, Kupferberg JP, Moss J, Fahey MR, Cannon JE, Miller RD (1988) Vecuronium inhibits histamine Nmethyltransferase. Anesthesiology 69: 92–96

    PubMed  CAS  Google Scholar 

  114. Ghoneim MM, Kranner SE, Bannow R, Pandya H, Routh JI (1973) Binding of d-tubocurarine to plasma proteins in normal man and in patients with hepatic or renal disease. Anesthesiology 39: 410–415

    PubMed  CAS  Google Scholar 

  115. Gibson FM, Mirakhur RK, Clarke RSJ, Lavery GG (1985) Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium. Br J Anaesth 57: 1060–1062

    PubMed  CAS  Google Scholar 

  116. Gilly H, Redl G, Streinzer W, Zrunek M, Draxler V (1986) Zur Pharmakodynamik von Vecuronium an Stimmband-and Thenarmuskulatur. Anaesthesist 35: 661

    PubMed  CAS  Google Scholar 

  117. Glass PSA, Ginsberg B, Quill T, Shafron D, Ascher J, Douglas C (1988) Onset, duration and reversal following doxacurium chloride (BW A938U) when combines with isoflurane. Anesth Analg 67: S73

    Google Scholar 

  118. Glass PSA, Wilson W, Mace JA, Wagoner R (1989) Is the priming principle both effective and safe? Anesth Analg 68: 127–134

    PubMed  CAS  Google Scholar 

  119. Glisson SN, Sanchez MM, El-Etr AA, Lim RA (1980) Nitroglyzerin and neuromuscular blockade produced by gallamine, sucinylcholine, d-tubocurarine, and pancuronium. Anesth Analg 59: 117–122

    PubMed  CAS  Google Scholar 

  120. Goedde H, Doenicke A, Altland K (1967) Pseudocholinesterasen. Springer, Berlin Heidelberg New York

    Google Scholar 

  121. Goldberg ME, Larijani GE, Sosis M, Azad SS, Williams JJ, Lessin JB, Man AT, Loces PF, Asher J, Weakly JN, Seltzer JL (1988) A comparison of endotracheal intubation conditions and recovery following intubating doses of mivacurium chloride or succinylcholine in outpatient surgery. Anesth Analg 67: 577

    Google Scholar 

  122. Goudsouzian NG, Alifmoff JK, Liu LMP, Foster V, Mc Nulty B, Savarese JJ (1989) Neuromuscular and cardiovascular effects of doxacurium in children anaesthetized with halothane. Br J Anaesth 62: 263–268

    PubMed  CAS  Google Scholar 

  123. Goudsouzian NG, Chakravorti S, Denman W, deBros F, Patel S (1994) Lack of accumulation of the cis-cis isomer of mivacurium in patients with low plasma cholinesterase activity. Anesthesiology 81: A1060

    Google Scholar 

  124. Goudsouzian NG, Denman W, Schwartz A, Shorten G, Foster V, Samara B (1993) Pharmacodynamic and hemodynamic effects of mivacurium in infants anesthetized with halothane and nitrous oxide. Anesthesiology 79: 919–925

    PubMed  CAS  Google Scholar 

  125. Gramstad L (1987) Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine. Br J Anaesth 59: 995–1003

    PubMed  CAS  Google Scholar 

  126. Gravlee GP, Ramsey FM, Roy RC, Angert KC, Rogers AT, Pauca AL (1988) Rapid administration of a narcotic and neuromuscular blocker: a hemodynamic comparison of fentanyl, sufentanil, pancuronium, and vecuronium. Anesth Analg 67: 39–47

    PubMed  CAS  Google Scholar 

  127. Griffith HR, Johnson GE (1942) The use of curare in general anesthesia. Anesthesiology 3: 412–420

    Google Scholar 

  128. Gronert GA, Theye RA (1974) Effect of succinylcholine on skeletal muscle with immobilization atrophy. Anesthesiology 40: 268–271

    PubMed  CAS  Google Scholar 

  129. Gronert GA, Theye RA (1975) Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 43: 89–99

    PubMed  CAS  Google Scholar 

  130. Gärtner T, Kreutzberg G, Doenicke A (1963) Comparative studies on cholinesterase activity in serum and liver cells. Acta Anaesthesiol Scand 7: 69

    Google Scholar 

  131. Harle DG, Baldo BA, Fisher MM (1985) Cross-reactivity of metocurine, atracurium, vecuronium and fazadinium with IgE antibodies from patients unexposed to these drugs but allergic to other myoneural blocking drugs. Br J Anaesth 57: 1073–1076

    PubMed  CAS  Google Scholar 

  132. Harris MM, Stirt JA, Broaddus WF, Cook DR (1987) Cerebrospinal fluid laudanosin kinetics in children. Anesthesiology 67: A506

    Google Scholar 

  133. Harris W, Whittaker M (1961) Differential inhibition of human serum cholinesterase with fluoride; recognition of two new phenotypes. Nature (Lond) 191: 496–498

    CAS  Google Scholar 

  134. Harrison GA (1972) The cardiovascular effects and some relaxant properties of four relaxants in patients about to undergo cardiac surgery. Br J Anaesth 44: 485–494

    PubMed  CAS  Google Scholar 

  135. Hartmann GS, Fiamengo SA, Riker WF (1986) Succinylcholine: mechanism of fasciculations and their prevention by d-tubocurarine or diphenyhydantoin. Anesthesiology 65: 405–413

    Google Scholar 

  136. Helpap B, Gullotta F, Schulte am Esch J (1983) Maligne Hyperthermie. Thieme, Stuttgart New York (Intensivmed Notfallmed Anästh Bd 42 )

    Google Scholar 

  137. Hennis PJ, Stanski DR (1985) Pharmacokinetic and pharmacodynamic factors that govern the clinical use of muscle relaxants. In: Katz RL (ed) Muscle relaxants. Grune & Stratton, Orlando, p 179

    Google Scholar 

  138. Hilgenberg JC (1983) Comparison of the pharmacology of vecuronium and atracurium with that of other currently available muscle relaxants. Anesth Analg 62: 524

    PubMed  CAS  Google Scholar 

  139. d’Hollander A, Massaux F, Nevelsteen M, Agoston SJ (1982) Age-dependent dose-response relationship of ORG NC45 in anaesthetized patients. Br J Anaesth 54: 653–657

    PubMed  Google Scholar 

  140. Holle F, Doenicke A (1961) Cholinesterase in der Chirurgie. In: Bauer KH, Brunner A, Lindemann K (Hrsg) Ergebnisse der Chirurgie und Orthopädie, Bd 63, Springer, Berlin Göttingen Heidelberg, S 77

    Google Scholar 

  141. d’Honneur G, Gerard A, Gall O, Rimaniol JM, Duval-destin P (1992) Effect of vecuronium priming dose on swallowing reflex. Anesthesiology 77: A936

    Google Scholar 

  142. d’Honneur G, Gerard A, Gall O, Rimaniol JM, Duvaldestin P (1992) Swallowing reflex priming doses of atracurium. Anesthesiology 7: A935

    Google Scholar 

  143. Hughes R (1985) Local reactions and histamine release by atracurium. Anaesthesia 40: 593–594

    PubMed  CAS  Google Scholar 

  144. Hunt R, Taveau RM (1906) On the physiological action of certain choline derivatives and new methods for detecting choline. Br Med J 2: 1788–1791

    Google Scholar 

  145. Hunter JM, Jones RS, Utting JE (1984) Comparison of vecuronium, atracurium and tubocurarine in normal patients and in patients with no renal function. Br J Anaesth 56: 941

    PubMed  CAS  Google Scholar 

  146. Ilias W, Lackner F, Zekert F (1985) Nifedipin und Vecuroniumbromid. Anaesthesist 34: 591–592

    PubMed  CAS  Google Scholar 

  147. Ilias W, Steinbereithner K (1985) Zur Wechselwirkung der Ca-Antagonisten Nifedipin und Nisoldipin mit dem nichtdepolarisierenden Muskelrelaxans Vecuroniumbromid im „in vivo“ Rattenpräparat. Anaesthesist 34: 588

    PubMed  CAS  Google Scholar 

  148. Inoue K, El-Banayosy A, Stolarski L, Reichelt W (1988) Vecuronium induced bradycardia following induction of anaesthesia with etomidate or thiopentone, with or without fentanyl. Br J Anaesth 60: 10–17

    PubMed  CAS  Google Scholar 

  149. Jantzen J-PAH (1988) Anaesthesie und intraokularer Druck. Anaesthesist 37: 458–469

    PubMed  CAS  Google Scholar 

  150. Joseph MM, Beatie C (1987) Effect of succinylcholine on recovery from vecuronium - a comparison of orbicularis oculi and adductor pollicis muscles. Anesthesiology 67: A342

    Google Scholar 

  151. Kalli I, Meretoja OA (1988) Infusion of atracurium in neonates, infants and children. A study of dose requirements. Br J Anaesth 60: 651

    Google Scholar 

  152. Kalow W, Davies RO (1958) The activity of various esterase inhibitors towards atypical human serum cholinesterase. Biochem Pharmacol 1: 183

    Google Scholar 

  153. Kalow W, Genest K (1957) A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucain numbers. Can J Biochem Physiol 35: 339–346

    Google Scholar 

  154. Kambam JR, Sastry BVR (1988) The effect of vecuronium on cholin acetyl transferase activity. 9th WCA Abstracts Vol II: A0543

    Google Scholar 

  155. Kaplan JA (1987) Cardiac anesthesia, 2nd ed, vol I, Saunders, Philadelphia London, p 151

    Google Scholar 

  156. Katz JA, Fragen RJ, Shanks CA, Dunn K, Mc Nulty B, Rudd GD (1989) Dose-response relationships of doxacurium chloride in humans during anesthesia with nitrous oxide and fentanyl, enflurane, isoflurane, or halothane. Anesthesiology 70: 432–436

    PubMed  CAS  Google Scholar 

  157. Katz B, Thesleff S (1957) A study of „desensitization“ produced by acetylcholine at the motor end-plate. J Physiol (Lond) 138: 63–80

    CAS  Google Scholar 

  158. Keens SJ, Hunter JM, Snowdon SL, Utting JE (1987) Potentiation of the neuromuscular blockade produced by alcuronium with halothane, enflurane and isoflurane. Br J Anaesth 59: 1011–1016

    PubMed  CAS  Google Scholar 

  159. Kelly RE, Dinner M, Turner LS, Haik B, Abramson DH, Daiens P (1993) Succinylcholine increases intra-ocular pressure in the human eye with the extraocular muscles detached. Anesthesiology 79: 948–952

    PubMed  CAS  Google Scholar 

  160. Kennedy BR, Kelman GR (1970) Cardiovascular effects of alcuronium in man. Br J Anaesth 42: 625

    PubMed  CAS  Google Scholar 

  161. Khalil M, d’Honneur G, Duvaldestin P, Slavov V, Gomeni R (1994) Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis. Anesthesiology 80: 1241–1247

    PubMed  CAS  Google Scholar 

  162. Kim C, Fuke N, Martyn JAJ (1988) Burn injury to rat increases nicotinic acetylcholine receptors in the diaphragm. Anesthesiology 68: 401–408

    PubMed  CAS  Google Scholar 

  163. Kohlschütter B, Baur H, Roth F (1976) Suxamethonium-induced hyperkalaemia in patients with severe intraabdominal infections. Br J Anaesth 48: 557–561

    PubMed  Google Scholar 

  164. Krieg N (1985) Pharmakodynamische Untersuchungen mit Vecuronium. Anaesthesist 34: 340

    PubMed  CAS  Google Scholar 

  165. Krieg N, Crul JF, Booij LHDJ (1980) Relative potency of ORG NC45, pancuronium, atracurium and tubo-curarne in anaesthetized man. Br J Anaesth 52: 783

    PubMed  CAS  Google Scholar 

  166. Krieg N, Hendrick HL, Crul JF (1981) Influence of suxamethonium on the potency of ORG NC45 in anaesthetized patients. Br J Anaesth 53: 259–262

    PubMed  CAS  Google Scholar 

  167. Kupferberg JP, James L, Seals CF (1987) Atracurium: inhibition of plasma cholinesterase and degradation in vitro. Anesthesiology 67: A602

    Google Scholar 

  168. Laurence AS (1987) Myalgia and biochemical changes following intermittent suxamethonium administration. Anaesthesia 42: 503–510

    PubMed  CAS  Google Scholar 

  169. Laurence AS (1988) Serum myoglobin release following suxamethonium administration to children. Eur J Anaesth 5: 31–38

    CAS  Google Scholar 

  170. Laycock JRD, Baxter MK, Bevan JC, Sangwan S, Donati F, Bevan DR (1988) The potency of pancuronium at the adductor pollicis and diaphragm in infants and children. Anesthesiology 68: 908–911

    PubMed  CAS  Google Scholar 

  171. Lebowitz PW, Ramsey FM, Savarese JJ, Ali HH, Bros de FM (1981) Combination of pancuronium and metocurine: neuromuscular and hemodynamic advantages over pancuronium alone. Anesth Analg 60: 12–17

    CAS  Google Scholar 

  172. Lebrault C, Berger JL, d’Hollander AA, Gomeni R, Henzel D, Duvaldestin P (1985) Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) in patients with cirrhosis. Anesthesiology 62: 601–605

    PubMed  CAS  Google Scholar 

  173. Lee C (1985) Succinylcholine: its past, present and 191. future. In: Katz RL (ed) Muscle relaxants. Grune & Stratton, Orlando, p 69

    Google Scholar 

  174. Leigh MD, Mc Coy DD, Belton KM (1957) Brady- 192. cardia following intravenous administration of succinylcholine chloride to infants and children. Anesthesiology 18: 698–702

    PubMed  CAS  Google Scholar 

  175. Lepage JY, Malinovsky JM, Debord P, Farinotti R, 193. Bidault R (1992) Pharmacokinetics of doxacurium in elderly patients. Anesthesiology 77: A911

    Google Scholar 

  176. Lepage JY, Malinovsky JM, Malinge M, Cozian A, Pinaud M (1993) 51W89: dose-response, neuromuscu- 194. lar blocking profile and cardiovascular effects. Anesthesiology 79: A945 195.

    Google Scholar 

  177. Lepage JY, Malinovsky JM, Malinge M, Cozian A, Pinaud M (1994) Comparison of equipotent doses of 51W89 and atracurium. Anesthesiology 81: A1090

    Google Scholar 

  178. Lepage JY, Malinovsky JM, Malinge M, Cozian A, 196. Pinaud M (1994) Pharmacodynamics and histamine releasing potency of high dose of 51W89. Anesthesiology 81: A1077 197.

    Google Scholar 

  179. Lidell J, Lehmann M, Silk E (1962) A silent pseudocholinesterase gene. Nature (Loud) 193: 561–562

    Google Scholar 

  180. Lien CA, Belmont MR, Abalos A, Abou-Donia M, Savarese JJ (1993) Dose-response relations of 51W89 under nitrous-oxide-opioid-barbiturate anesthesia. 198. Anesthesiology 79: A948

    Google Scholar 

  181. Lien CA, Schmidt VD, Belmont MR, Kisor D, Savarese JJ (1994) Pharmacokinetics/dynamics of 51W89 199. in healthy patient during opioid anesthesia. Anesthesiology 81: A1082 200.

    Google Scholar 

  182. Lien CA, Schmidt VD, Embree PB, Belmont MR, Wargin WA, Savarese JJ (1994) The pharmacokinetics 201. and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/ barbiturate anesthesia. Anesthesiology 80: 1296–1302

    PubMed  CAS  Google Scholar 

  183. Lincoff HA, Breinin GM, De Voe AG (1957) The effect 202. of succinylcholine on the extraocular muscles. Am J Ophthalmol 43: 440

    PubMed  CAS  Google Scholar 

  184. Maddineni VR, McCoy EP, Mirakhur RK, Stanley JC, 203. Lyons SM (1993) Mivacurium in the elderly: comparison of neuromuscular and hemodynamic effects with adults. Anesthesiology 79: A964

    Google Scholar 

  185. Maddineni VR, Mirakhur RK (1993) Prolonged neuro- 204. muscular block following mivacurium. Anesthesiology 78: 1181–1184

    PubMed  CAS  Google Scholar 

  186. Magorian T, Flannery KB, Miller RD (1993) Compari- 205. son of rocuronium, succinylcholine, and vecuronium for rapid sequence induction of anesthesia in adult patients. Anesthesiology 79: 913–918

    PubMed  CAS  Google Scholar 

  187. Martyn JAJ, White DA, Gronert MD, Jaffe RS, Ward JM (1992) Up-and-down regulation of skeletal muscle 206. acetylcholine receptors. Anesthesiology 76: 822–843

    PubMed  CAS  Google Scholar 

  188. Matteo RS (1985) Neuromuscular blockade. Use in the elderly. Clin Anaesth 3: 421–434

    Google Scholar 

  189. Matteo RS, Nishitateno K, Pua EK, Spector S (1980) 207. Pharmacokinetics of d-tubocurarine in man: effect of an osmotic diuretic on urinary excretion. Anesthesiology 52: 335–338 208.

    Google Scholar 

  190. Matteo RS, Pua EK, Khambatta HJ, Spector S (1977) Cerebrospinal fluid levels of d-tubocurarine in man. 209. Anesthesiology 46: 396–399

    PubMed  CAS  Google Scholar 

  191. Mayer M, Doenicke A, Hofmann A, Peter K (1992) Onset and recovery of rocuronium (ORG 9426) and 210. vecuronium under enflurane anaesthesia. Br J Anaesth 69: 511–512

    PubMed  CAS  Google Scholar 

  192. Mayer M, Doenicke A, Lorenz W, Neubauer AE, Rüll T, Kapp B, Peter K (1992) Histamine releasing potency of rocuronium. Anesthesiology 77: A906

    Google Scholar 

  193. Mayer M, Doenicke A, Nebauer AE, Rosenberger C, Lorenz W, Peter K (1993) Pharmakodynamik und klinische Nebenwirkungen von Mivacurium. Anaesthesist 42: 592–596

    Google Scholar 

  194. Meakin G, Shaw EA, Baker RD, Morris P (1988) Comparison of atracurium-induced neuromuscular blockade in neonates, infants and children. Br J Anaesth 60: 171–175

    Google Scholar 

  195. Mercer JD (1984) A severe anaphylactic reaction of atracurium Anaesth Intensive Care 12: 262

    CAS  Google Scholar 

  196. Meretoja OA, Wirtavuori K, Neuvonen PJ (1988) Age-dependence of the dose-response curve of vecuronium in pediatric patients during balanced anesthesia. Anesth Analg 67: 21–26

    PubMed  CAS  Google Scholar 

  197. Merrett RA, Thomspon CW, Webb FW (1983) In vitro degradation of atracurium in human plasma. Br J Anaesth 55: 61–66

    PubMed  CAS  Google Scholar 

  198. Metha MP, Sokoll MD, Gergis SD (1988) Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine. Eur J Anaesth 5: 15–21

    Google Scholar 

  199. Miller KW, Paton WDM, Smith RA (1973) Pressure reversal of anaesthesia and the critical volume hypothesis. Mol Pharmacol 9: 131

    PubMed  CAS  Google Scholar 

  200. Miller RD (1982) Pharmacokinetics of competitive muscle relaxants. Br J Anaesth 54: 161

    PubMed  CAS  Google Scholar 

  201. Miller RD (1985) Neuromuscular blockade, Effect of renal disease. Clin Anaesth 3: 307–313

    Google Scholar 

  202. Miller RD, Agoston A, Van der Pol, Booij LHDJ, Crul JF, Ham J (1978) Hypothermia and pharmacokinetics and pharmacodynamics of pancuronium in the cat. J Pharmacol Exp Ther 207: 532–538

    PubMed  CAS  Google Scholar 

  203. Miller RD, Rupp SM, Fisher DM, Cronnelly R, Fahey MR, Sohn YJ (1984) Clinical pharmacology of vecuronium and atracurium. Anesthesiology 61: 444–453

    PubMed  CAS  Google Scholar 

  204. Miller RD, Way WL (1971) Inhibition of succinylcholine induced increased intragastric pressure by nondepolarizing muscle relaxants and lidocain. Anesthesiology 34: 185–188

    PubMed  CAS  Google Scholar 

  205. Miller RD, Way WL, Hamilton WK, Layzer RB (1972) Succinylcholine-induce hyperkalemia in patients with renal failure? Anesthesiology 36: 138–141

    PubMed  CAS  Google Scholar 

  206. Miller RD, Way WL, Dolan MW, Stevens WC, Eger EI II (1972) The dependence of pancuronium and d-tubocurarine induced neuromuscular blockades on alveolar concentration of halothane and forane. Anesthesiology 37: 573–581

    PubMed  CAS  Google Scholar 

  207. Minton MD, Grosslight K, Stirt JA, Bedford RF (1986) Increased in intracranial pressure from succinylcholine: prevention by prior nondepolarizing blockade. Anesthesiology 65: 165–169

    PubMed  CAS  Google Scholar 

  208. Mirakhur RK, Joes CJ, Dundee JW (1980) Effects of intravenous administration of glycopyrrolate and atropine in anaesthetized patients. Anaesthesia 36: 277–281

    Google Scholar 

  209. Mishima S, Yamamura T (1984) Anaphylactoid reaction to pancuronium. Anesth Analg 63: 865

    Google Scholar 

  210. Moss J, Rosow CE, Savarese JJ, Philbin DM, Kniffen ICJ (1981) Role of histamine in the hypotensive action of d-tubocurarine in humans. Anesthesiology 55: 19–25

    Google Scholar 

  211. Moss J, Rosow CE (1983) Histamine release by narcotics and muscle relaxants in humans Anesthesiology 59: 330–339

    Google Scholar 

  212. Motsch J, Fuchs W, Hoch P, Kass V, Hutschenreuter K 229. (1987) Side effects and changes in pulmonary function after fixed dose precurarization with alcuronium, pancuronium or vecuronium. Br J Anaesth 59: 1528 230.

    Google Scholar 

  213. Musich J, Walts LF (1986) Pulmonary aspiration after a priming dose of vecuronium. Anesthesiology 64: 517–519

    PubMed  CAS  Google Scholar 

  214. Nachmansohn D (1963) The chemical basis of Claude Bernard’s observation on curare. Biochem Z 338: 454 231

    Google Scholar 

  215. Naguib M (1994) Neuromuscular effects of rocuronium bromide and mivacurium chloride administered alone and in combination. Anesthesiology 81: 388–395

    PubMed  CAS  Google Scholar 

  216. Nigrovic V, Pandya JB, Auen M, Wajskol A (1985) 232. Inactivation of atracurium in human and rat plasma. Anesth Analg 64: 1047–1052

    Google Scholar 

  217. O’Hara DA, Fragen RJ, Shanks CA (1985) The effets 233. of age on the dose-reponse curves for vecuronium in adults. Anesthesiology 63: 542–544

    PubMed  Google Scholar 

  218. Ornstein E, Lien C, Matteo RS, Ostapkovich N, Wolf 234 K, Kisor K, Diaz J (1994) Pharmacodynamics and pharmacokinetics of 51W89 in geriatric surgical patients. Anesthesiology 81: A1075

    Google Scholar 

  219. Ornstein E, Matteo RS, Weinstein JA, Young WL 235. (1988) The effect of maintanance dose vecuronium of metocurine induced neuromuscular blockade. Anesthesiology 69: 954

    PubMed  CAS  Google Scholar 

  220. Ostergaard D, Jensen E, Jensen FS, Mogensen JV 236. (1991) The duration of action of mivacurium -induced neuromuscular block in patients homozygous for the atypical plasma cholinesterase gene. Anesthesiology 75: A774 237.

    Google Scholar 

  221. O’Sullivan EP, Williams NE, Calvey TN (1988) Differential effects of neuromuscular blocking agents on suxamethonium-induced fasciculations and myalgia. 238. Br J Anaesth 60: 367

    PubMed  Google Scholar 

  222. Oyos TL, Lillehaug SL, Harley PJ, Downs DD, Patel SS, Gergis SD, Sokoll MD (1994) A study of the safety and efficacy of 51W89 in surgical patients during N2O/02/opioid, N2O/02/isoflurane, N2O/02/enflurane, 239. and N2O/O2/propofol anesthesia. Anesthesiology 81: A1117

    Google Scholar 

  223. Pandey K, Badola RP, Kumar S (1972) Time course of intraocular hypertension produced by suxamethonium. 240. Br J Anaesth 44: 191–196

    PubMed  CAS  Google Scholar 

  224. Panning B, Peest D, Kirchner E, Schedel I (1985) Anaphylaktoider Schock nach Alloferin. Anaesthesist 34: 211–212 241.

    Google Scholar 

  225. Pansard IL, Chauvin M, Lebrault C, Gauneau P, Duvaldestin P (1987) Effect of an intubating dose succinylcholine and atracurium on the diaphragm and the adductor pollicis muscle in humans. Anesthesio- 242. logy 67: 326–330

    CAS  Google Scholar 

  226. Parker CJR, Hunter JM (1988) The pharmacokinetics of atracurium and its metabolite, laudanosine, in the cirrhotic patient. 9th WCA Abstr Sci Pap vol II: A5014

    Google Scholar 

  227. Paskow DS, Agoston S, Bowman WC (1986) 4-Ami- 243. nopyridin hydrochloride (pymadin). In: Kharkevich DA (ed) New neuromuscular blocking agents. Springer, Berling Heidelberg New York Tokyo (Handbook 244. of experimental pharmacology, vol 79, p 679 )

    Google Scholar 

  228. Patel R, Katz R (1994) The effect of mivacurium on Atracurium preestablished doxacurium of mivacurium block. Anesthesiology 81: A1068

    Google Scholar 

  229. Paton WDM, Waud DR (1967) The margin of safety of 245. muscle relaxant drugs. J Physiol (Lond) 191: 59–90

    CAS  Google Scholar 

  230. Plötz J, Braun J (1987) Der Einfluß ausgewählter Narkotika auf die Serumkonzentration von Myoglobin nach Gabe von Succinylcholin. Anaesthesist 36: 352

    Google Scholar 

  231. Plötz J, Kutz N, Sommerburg C, Braun J (1989) Injektionsgeschwindigkeit von Succinylcholin and neuro-muskulärer Wirkungseintritt, Serumkalium-bzw. myoglobinkonzentration. Untersuchungen bei Männern in Halothannarkose. Anaesthesist 38: 408

    Google Scholar 

  232. Proakis AG, Harris GB (1978) Comparative penetration of glycopyrrolate and atropine across the blood-brain and placental barriers in anesthetized dogs. Anesthesiology 48: 339–344

    PubMed  CAS  Google Scholar 

  233. Pusey JM, Charlton SM, Skinner JB, Assem ESK (1987) Anaphylactoid reaction to alcuronium. Anaesthesia 42: 164–167

    PubMed  CAS  Google Scholar 

  234. Quill TJ, Glass PSA (1988) Vecuronium by continuous infusion: comparative study. 9th WCA Abstracts vol II: A 0538

    Google Scholar 

  235. Ramsey FM, Morell RC, Gerr P (1986) The priming principle: pretreatment with metocurine prior to vecuronium neuromuscular blockade. Anesthesiology 65: A298

    Google Scholar 

  236. Robertson EN, Hull JM, Vanlinthout LEH, Booij LHDJ (1994) Pharmacodynamics of rocuronium and succinylcholine and their effects on BP, HR, and IOP. Anesthesiology 81: A1071

    Google Scholar 

  237. Rorvik K, Husby P, Gramstad L, Vamnes JS, BitschLarsen L, Koller ME (1988) Comparison of large dose vecuronium with pancuronium for prolonged neuromuscular blockade. Br J Anaesth 61: 180–185

    Google Scholar 

  238. Rowlands DE (1987) Harmless cutaneous reactions associated with the use of atracurium. A reprot of 1200 anaesthetics. Br J Anaesth 59: 693

    PubMed  CAS  Google Scholar 

  239. Rupp SM, Mc Christian JW, Miller RD, Taboada JA, Cronnelly R (1986) Neostigmine and endrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium or vecuronium. Anesthesiology 64: 711–717

    PubMed  CAS  Google Scholar 

  240. Rupp SM, Miller RD, Gencarelli P (1984) Vecuronium-induced neuromuscular blockade during enflurane, isoflurane and halothane anesthesia in humans. Anesthesiology 60: 102–105

    PubMed  CAS  Google Scholar 

  241. Salmenpera M, Peltola K, Takkumen O, Heinonen J (1983) Cardiovascular effects of pancuronium and vecuronium during high-dose fentanyl anesthesia. Anesth Analg 62: 1059–1064

    Google Scholar 

  242. Salvatore A, Del Pozo E, Carlos R, Baeyens JM (1988) Differential effects of calcium channel blocking agents on pancuronium-and suxamethonium-induced neuromuscular blockade. Br J Anaesth 60: 495–499

    Google Scholar 

  243. Sarner JB, Brandom BW, Woelfel SK, Dong M-L, Horn MC, Cook DR, Mc Nulty BF, Foster VJ (1989) Clinical pharmacology of mivacurium chloride (BW 1090 U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth Analg 68: 116–121

    PubMed  CAS  Google Scholar 

  244. Savarese JJ, Ali HH, Antonio RP (1977) The clinical pharmacology of metocurine: dimethyltubocurarine revisited. Anesthesiology 47: 277–284

    PubMed  CAS  Google Scholar 

  245. Savarese JJ, Ali HH, Basta SJ, Embree PM, Scott RPF, Sunder M, Neal Weakly J, Wastila WB, El-Sayad HA (1988) The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). Anesthesiology 68: 723–732

    PubMed  CAS  Google Scholar 

  246. Schuh FT (1977) Zur Cholinesterase-Hemmung durch Pancuronium. Anaesthesist 26: 125–129

    PubMed  CAS  Google Scholar 

  247. Schuh FT (1981) Pathophysiologische Bedingungen als Kontraindikationen für den Einsatz de-polarisierender Muskelrelaxantien. In: Buzello W (Hrsg) Muskelrelaxantien. Thieme, Stuttgart New York (Intensivmed Notfallmed Anästh, Bd 30, S 112 )

    Google Scholar 

  248. Schwarz S, Ilias W, Lackner F, Mayrhofer O, Foldes FF (1985) Rapid tracheal intubation with vecuronium: the priming principle. Anesthesiology 62: 388–391

    PubMed  CAS  Google Scholar 

  249. Scott RPF, Savarese JJ, Basta SJ, Sunder N, Ali HH, Gargarian M, Gionfriddo M, Batson AG (1985) Atra-curium: clinical strategies for preventing histamine release and attenuating the haemodynamic response. Br J Anaesth 51: 550–553

    Google Scholar 

  250. Sessler DI, Olofsson CI, Chow F (1988) Lower esophageal contractility predicts movement during skin incision: vecuronium does not decrease the MAC of halothane. Anesth Analg 67: S 201

    Google Scholar 

  251. Shanks CA (1986) Pharmakokinetics of the nondepolarizing neuromuscular relaxants applied to calculation of bolus and infusion dosage regimens. Anesthesiology 64: 72–86

    PubMed  CAS  Google Scholar 

  252. Shanks CA, Somogyi AA, Triggs EJ (1979) Dose-response and plasma concentration-response relationships of pancuronium in man. Anesthesiology 51: 111–118

    PubMed  CAS  Google Scholar 

  253. Silverman DG, Mirakhur RK (1994) Nondepolarizing relaxants of the 1990s. In: Silverman DG (ed) Neuromuscular block in perioperative and intensive care. Lippincott, Philadelphia p 201–216

    Google Scholar 

  254. Smith CE, Donati F, Bevan DR (1988) Potency of succinylcholine at the diaphragm and the adductor pollicis muscle. Anesth Analg 67: 625–630

    PubMed  CAS  Google Scholar 

  255. Smith G, Dalling R, Williams TIR (1978) Gastrooesophageal pressure gradient changes produced by induction of anaesthesia and suxamethonium. Br J Anaesth 50: 1137–1142

    PubMed  CAS  Google Scholar 

  256. Smith RB, Grenvik A (1970) Cardiac arrest following succinylcholin in patients with central nervous system injuries. Anesthesiology 33: 558–560

    PubMed  CAS  Google Scholar 

  257. Sold M, Lazarus G, Baar H (1987) Untersuchungen zur Antagonisierbarkeit einer Intubationsdosis Vecuronium. Anaesthesist 36: 345

    PubMed  CAS  Google Scholar 

  258. Spek Van Der AFL, Fang W, Ashton-Miller JA, Stohler CS, Carlson DS, Schork MA (1988) Increased masticatory muscle stiffness during limb muscle flaccidity associated with succinylcholine administration. Anesthesiology 69: 11–16

    PubMed  Google Scholar 

  259. Spence AG, Barnetson RStC (1985) Reaction to vecuronium bromide. Lancet I: 979

    Google Scholar 

  260. Stanec A, Baker T (1988) A prejunctional synergism of potent inhalation gases and pancuronium. 9th W Congr Abstr Sc Pap II: A0566

    Google Scholar 

  261. Starr NJ, Sethna DH, Estafanous FG (1986) Brady-cardia and asystole following the rapid administration of sufentanil with vecuronium. Anesthesiology 64: 521–523

    PubMed  CAS  Google Scholar 

  262. Stenlake JB, Waigh RD, Urwin J, Dewar GH, Coker GG (1983) Atracurium. Conception and inception. Br J Anaesth 55: 3S

    Google Scholar 

  263. Stirt JA, Grosslight KR, Bedford RF, Vollmer D (1987) „Defasciculation“ with metocurine prevents succinylcholine-induced increases in intracranial pressure. Anesthesiology 67: 50–53

    Google Scholar 

  264. Stoelting PK (1972) The hemodynamic effects of pancuronium and d-tubocurarine in anesthetized patients. Anesthesiology 36: 612–615

    PubMed  CAS  Google Scholar 

  265. Stoelting RK (1977) Comparison of gallamine and atropine as pretreatment before anesthetic induction and succinylcholine administration. Anesth Analg 56: 493–495

    PubMed  CAS  Google Scholar 

  266. Stoops CM, Curtis CA, Kovach DA, Mc Cammon RL, Stoelting RK, Warren TM, Miller D, Bopp SK, Jugovic DJ, Abou-Dovia MM (1989) Hemodynamic effects of mivacurium chloride administered to patients during oxygen-sufentanil anesthesia for coronary artery bypass grafting or value replacement. Anesth Analg 68: 333–339

    PubMed  CAS  Google Scholar 

  267. Stovner J, Oftedal N, Holmboe I (1975) The inhibition of cholinesterases by pancuronium. Br J Anaesth 47: 949–954

    PubMed  CAS  Google Scholar 

  268. Sugimori T (1986) Shortended action of succinylcholine in induviduals with cholin-esterase C5 isoenzyme. Can Anaesth Soc J 33: 321–327

    PubMed  CAS  Google Scholar 

  269. Swerdlow BN, Holley FO (1987) Intravenous anaesthetic agents. Pharmacokinetic - pharmacodynamic relationships. Clin Pharmacokin 12: 79–110

    Google Scholar 

  270. Szenohradszky J, Fisher DM, Segredo V, Caldwell JE, Bragg P, Sharma ML, Gruenke LD, Miller RD (1992) Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 77: 899–904

    PubMed  CAS  Google Scholar 

  271. Tabaoda JA, Rupp SM, Miller RD (1986) Refining the priming principle for vecuronium during rapid–sequence induction of anesthesia. Anesthesiology 64: 243–247

    Google Scholar 

  272. Taivainen T, Meretoja OA, Erkola O, Rautoma P, Juvakoski M (1994) Rocuronium in infants, children and adults. Anesthesiology 81: A1074

    Google Scholar 

  273. Tassony E, Pittet J-F, Schopfer C, Gemperle G, Rouge J-C, Morel DR (1991) Pharmacokinetics of pipecuronium in infants, children and adults. Anesthesiology 75: A777

    Google Scholar 

  274. Taylor P (1985) Are neuromuscular blocking agents more efficacious in pairs? Anesthesiology 63: 1–3

    PubMed  CAS  Google Scholar 

  275. Thomas J, Climie CR, Mather LE (1969) The placental transfer of alcuronium. Br J Anaesth 41: 297301

    Google Scholar 

  276. Thys DM, Konstadt SN, Reich D, Hillel Z, Keusch D, Gettes M, Guffin A, Kaplan JA, Mikula S, Marvin R (1988) The effects of a new muscle relaxant, doxacurium, on left and right ventricular performance. Anesth Analg 67: 5232

    Google Scholar 

  277. Tolmie JD, Joyce TH, Mitchell GD (1967) Succinylcholine danger in the burned patients. Anesthesiology 28: 467–470

    PubMed  CAS  Google Scholar 

  278. Trudell JR (1977) A unitary theory of anesthesia based on lateral phase separations in nerve membranes. Anesthesiology 46: 5

    PubMed  CAS  Google Scholar 

  279. Tryba M (1985) Wirkungsverstärkung nicht-depolarisierender Muskelrelaxantien durch Acylaminopenicilline. Anaesthesist 34: 651

    PubMed  CAS  Google Scholar 

  280. Tsui D, Graham GG, Torda DA (1987) The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology 67: 722–728

    PubMed  CAS  Google Scholar 

  281. Tuchy GL, Tuchy E, Bleyberg M, Smith GL, Calava J (1994) Pharmacodynamics of mivacurium in obese patients. Anesthesiology 81: A1069

    Google Scholar 

  282. Tullock WC, Diana P, Cook DR, Wilks DH, Brandom BW, Beach CA (1988) High dose vecuronium: onset and duration. Anesth Analg 67: S 235

    Google Scholar 

  283. Tullock WC, Scott V, Smith DA, Phillips L, Cook DR 302. (1994) Kinetics/Dynamics of 51 W 89 in liver transplant patients and in healthy patients. Anesthesiology 81: A1076 303.

    Google Scholar 

  284. Tullock WC, Wilks DH, Brandom BW, Cook DR (1991) ORG 9426: onset, intubating conditions, and clinical duration. Anesthesiology 75: A789

    Google Scholar 

  285. Ulsamer B (1988) Vecuroniumbromid: Beeinflussung 304. der Pharmakodynamik durch Etomidat, Cimetidin und Ranitidin. Anaesthesist 37: 504–509

    PubMed  CAS  Google Scholar 

  286. Valinthout LEH, de Wolff MH, van Egmond J, Booij LHDJ, Robertson EN (1994) The effect of 305. isoflurane and sevoflurane on the potency and recovery of neuromuscular blockade by vecuronium, pancuronium and atracurium. Anesthesiology 81: A1113 306.

    Google Scholar 

  287. Viby-Mogensen J (1985) Ineraction of other drugs with muscle relaxants. In: Katz RL (ed) Muscle relaxants. Grune & Stratton, Orlando, p 233

    Google Scholar 

  288. Viby-Mogensen J, Chraemmer-Jorgenson B, Ording H (1979) Residual curarization in the recovery room. 307. Anesthesiology 50: 539–541

    PubMed  CAS  Google Scholar 

  289. Vlasselaers D, Mulier JP, Berg H, Hom A, Van Aken H 308. (1994) Haemodynamic effects of a potent isomer of atracurium (51W89) in cardiac patients. Anesthesiology 81: A1079 309.

    Google Scholar 

  290. Wainwright AP, Brodrick PM (1987) Suxamethonium in myasthenia gravis. Anaesthesia 42: 950–957

    PubMed  CAS  Google Scholar 

  291. Wald-Oboussier G, Lohmann Ch, Vieil B, Doehn M (1987) „Self-taming“: eine Alternative zur Prophylaxe des durch Succinylcholin induzierten Schmerzes. 310. Anaesthesist 36: 426–430

    Google Scholar 

  292. Ward S, Boheimer N. Weatherley BC, Simmons RJ, Dopson TA (1987) Pharmacokinetics of atracurium and its metabolites in patient with normal renal function, and in patients in renal failure. Br J Anaesth 311. 59: 697–706

    Google Scholar 

  293. Ward S, Judge S, Corall I (1982) Pharmacokinetics of pancuronium bromide in liver failure. Br J Anaesth 54: 227 P

    Google Scholar 

  294. Ward S. Neill EAM (1983) Pharmacokinetics of atracurium in acute hepatic failure (with acute renal 312. failure). Br J Anaesth 55: 1169–1172

    Google Scholar 

  295. Waser PG (1986) Molekulare Pharmakologie und 313. Kinetik der Muskelrelaxanzien am Endorgan. Anästh Intensivmed 188: 180

    Google Scholar 

  296. Waser PG, Relier J (1972) Distribution and pharmacokinetics of 14C-toxiferine in rats. Agents Actions 2: 314. 170–175

    PubMed  CAS  Google Scholar 

  297. Waser PG, Wiederkehr H, Chang Sin-Ren A, KaiserSchönenberger E (1987) Distribution and kinetics of 14C-Vecuronium in rats and mice. Br J Anaesth 315. 59: 1044–1051

    Google Scholar 

  298. Waters DJ, Mapleson WW (1971) Suxamethonium pains. hypothesis and observation. Anaesthesia 26: 127 316.

    Google Scholar 

  299. Watkins J (1986) Histamine release and atracurium. Br J Anaesth 58:19 S-22S

    Google Scholar 

  300. Waud BE, Farrel L, Waud DR (1982) Lithium and neuromuscular transmission. Anesth Analg 61: 399–402

    PubMed  CAS  Google Scholar 

  301. Waud BE, Waud DR (1975) The effects of diethyl 317. ether, enflurane, and isoflurane at the neuromuscular junction. Anesthesiology 42: 275

    PubMed  CAS  Google Scholar 

  302. Waud BE, Waud DR (1985) Interaction among agents 318. that block end-plate depolarization competitively. Anesthesiology 63: 4–15

    PubMed  CAS  Google Scholar 

  303. Weber S, Powers DM, Byers RS, Mazloomdoost M (1988) Dose age affect use of the priming principle for rapid intubation? Anesth Analg 67: S250

    Google Scholar 

  304. Weinstein JA, Matteo RS, Ornstein E, Schwartz AE, Goldstoff M, Thal G (1988) Pharmacodynamics of vecuronium and atracurium in the obese surgical patients. Anesth Analg 67: 1149–1153

    PubMed  CAS  Google Scholar 

  305. Weintraub HD, Heisterkamp DV, Cooperman LH (1969) Changes in plasma concentration after depolarizing blockers in anaesthetized man. Br J Anaesth 41: 1048–1052

    PubMed  CAS  Google Scholar 

  306. Wessler I (1987) Modulation der Acetylcholin-Freisetzung aus dem motorischen Nerven durch präsynaptische Rezeptoren. Anaesthesist [Suppl] 36: 259

    Google Scholar 

  307. Whittaker M (1980) Plasma cholinesterase variants and the anaesthetist. Anaesthesia 35: 174–197

    PubMed  Google Scholar 

  308. Whittaker M (1986) Cholinesterase. In: Beckmann L (ed) Monographs in human genetics, vol 11. Karger, Basel, p 1

    Google Scholar 

  309. Wierda JMKH, Karliczek GF, van der Brom RHG, Kersten-Kleef UW, Agoston S (1987) Pharmacokinetics and cardiovascular effects of pipecuronium bromide ( Arduan) in CABG patients. Anesthesiology 67: A613

    Google Scholar 

  310. Wierda JMKH, Richardson FJ, Agoston S (1989) Dose-response relation and time course of action of pipecurnium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl. Anesth Analg 68: 208–213

    PubMed  CAS  Google Scholar 

  311. Wierda JMKH, Van Den Broek L, Proost JH, Smeulers NJ, Agoston S (1993) Time course of action and endotracheal intubating conditions of ORG 9487, a new short-acting steridal muscle relaxant: a comparison with succinylcholine. Anesth Analg 77: 579

    PubMed  CAS  Google Scholar 

  312. Wildsmith JAW (1972) Serum pseudocholinesterase, pregnancy and suxamethonium. Anaesthesia 27: 90

    PubMed  CAS  Google Scholar 

  313. Witkowski TA, Bartkowski RR, Azad SS, Marr A, Lessin J, Epstein RH (1992) ORG 9426 onset of action: Atracurium comparison with atracurium and vecuronium. Anesthesiology 77: A964

    Google Scholar 

  314. Woelfel SK, Brandom BW, Cook DR, Sarner JB (1992) Effects of bolus administration of ORG-9426 in children during nitrous oxide-halothane anesthesia. Anesthesiology 76: 939–942

    PubMed  CAS  Google Scholar 

  315. Wright PMC, Hart PS, Lau M, Brown R, Fisher DM (1994) Potentiation of vecuronium by desflurane vs. isoflurane. Anesthesiology 81: A1114

    Google Scholar 

  316. Yate PM, Flynn PJ, Arnold RW, Weatherley BC, Simmonds RJ, Dopson T (1987) Clincial experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit. Br J Anaesth 59: 211–217

    PubMed  CAS  Google Scholar 

  317. Young WL, Matteo RS, Ornstein E (1988) Duration of action of neostigmine and pyridostigmine in the elderly. Anesth Analg 67: 775–778

    PubMed  CAS  Google Scholar 

  318. Zsigmond EK, Down JR (1971) Plasma cholinesterase activity in newborns and infants. Can Anaesth Soc J 18: 278–282

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. B. Ulsamer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Doenicke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für experimentelle Anästhesiologie, Ludwig-Maximilians-Universität, Bereich Poliklinik, Pettenkoferstr. 8 a, D-80336, München, Deutschland

    Alfred Doenicke

  2. Zentrum Anästhesiologie, Rettungs- und Intensivmedizin, Universität Göttingen, Robert-Koch-Str. 40, D-37070, Göttingen, Deutschland

    Dietrich Kettler

  3. Universitätsklinik für Anästhesiologie, LKH Graz, Auenbruggerplatz, A-8036, Graz, Österreich

    Werner F. List

  4. Klinik für Anästhesiologie und Operative Intensivmedizin, Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Straße 40, D-06097, Halle (Saale), Deutschland

    Joachim Radke

  5. Institut für klinische Anästhesiologie, Heinrich-Heine-Universität Düsseldorf, Moorenstr. 5, D-40001, Düsseldorf, Deutschland

    Jörg Tarnow

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ulsamer, B., Doenicke, A. (1995). Muskelrelaxanzien. In: Doenicke, A., Kettler, D., List, W.F., Radke, J., Tarnow, J. (eds) Anästhesiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-97553-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-97553-0_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-97554-7

  • Online ISBN: 978-3-642-97553-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation